Literature DB >> 9849797

Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study.

C Rae1, R B Scott, C H Thompson, R M Dixon, I Dumughn, G J Kemp, A Male, M Pike, P Styles, G K Radda.   

Abstract

Duchenne muscular dystrophy (DMD) is a progressive muscle disorder associated with an intellectual deficit which is non-progressive. We obtained localised 1H magnetic resonance spectra from the left frontal lobe and left cerebellum of 15 boys with DMD (mean age 106 months+/-32) and 15 similarly aged control boys (mean age 115 months+/-31); all boys underwent a battery of neuropsychological tests. We found a significant (P<0.01) increase in the ratio of choline-containing compounds to N-acetylaspartate (Cho/NA) in the left cerebellum in boys with DMD compared with control boys. There was no change in the creatine/NA ratio and a significant increase (P=0.03) in the Cho/creatine ratio, suggesting that the change in Cho/NA ratio was due to an increase in choline-containing compounds; this increase has been previously observed in the brain of the murine model of DMD, the mdx mouse. No significant changes were observed in spectra obtained from left frontal lobe in DMD compared to controls. We also observed a significant association between Cho/NA in the left cerebellum, and the performance of DMD boys on the Matrix Analogies Test (MAT). The MAT is a test of visuo-spatial ability and non-verbal reasoning which requires neither manual dexterity nor a verbal response for an adequate performance. A comparison of DMD boys whose cerebellar Cho/NA fell within 2 standard deviations of the control norm (0.56+/-0.24) with DMD boys whose cerebellar Cho/NA was outside this range (i.e. >0.80) revealed a significant difference in ability on the MAT (P<0.05). DMD boys whose Cho/NA ratio is more than two standard deviations higher than controls perform significantly better on the MAT than DMD boys whose Cho/NA ratio is within the normal range. This finding suggests that the observed elevation in Cho/NA and Cho/creatine is not associated with intellectual deficit (as sampled by the MAT), and may represent a compensatory mechanism. The possible interpretations of these metabolic changes are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849797     DOI: 10.1016/s0022-510x(98)00190-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

2.  Effects of Sildenafil on Cerebrovascular Reactivity in Patients with Becker Muscular Dystrophy.

Authors:  Ulrich Lindberg; Nanna Witting; Stine Lundgaard Jørgensen; John Vissing; Egill Rostrup; Henrik Bo Wiberg Larsson; Christina Kruuse
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

3.  Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain.

Authors:  R E Jung; W M Brooks; R A Yeo; S J Chiulli; D C Weers; W L Sibbitt
Journal:  Proc Biol Sci       Date:  1999-07-07       Impact factor: 5.349

4.  Decreased gray matter concentration and local synchronization of spontaneous activity in the motor cortex in Duchenne muscular dystrophy.

Authors:  S-Y Lv; Q-H Zou; J-L Cui; N Zhao; J Hu; X-Y Long; Y-C Sun; J He; C-Z Zhu; Y He; Y-F Zang
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

5.  In Vivo Evaluation of White Matter Abnormalities in Children with Duchenne Muscular Dystrophy Using DTI.

Authors:  V Preethish-Kumar; A Shah; M Kumar; M Ingalhalikar; K Polavarapu; M Afsar; J Rajeswaran; S Vengalil; S Nashi; P T Thomas; A Sadasivan; M Warrier; A Nalini; J Saini
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

Review 6.  Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

Authors:  Mark G Rae; Dervla O'Malley
Journal:  J Neurophysiol       Date:  2016-07-06       Impact factor: 2.714

7.  Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.

Authors:  Su Xu; Da Shi; Stephen J P Pratt; Wenjun Zhu; Andrew Marshall; Richard M Lovering
Journal:  Neuromuscul Disord       Date:  2015-07-10       Impact factor: 4.296

Review 8.  Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.

Authors:  Malihe Mohamadian; Mandana Rastegar; Negin Pasamanesh; Ata Ghadiri; Pegah Ghandil; Mohsen Naseri
Journal:  J Mol Neurosci       Date:  2021-11-02       Impact factor: 3.444

Review 9.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

10.  Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome.

Authors:  Julian L Griffin; Christine Des Rosiers
Journal:  Genome Med       Date:  2009-03-25       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.